Those who carried this gene, known to increase the risk of Alzheimer's, experienced a decline in their ability to detect scents between the ages of 65 and 69.
A team identified a molecular compound that can activate latent HIV-1 in cells, offering promise for more effective HIV treatments and perhaps even a cure.
Scientists discovered a correlation between biomarkers in the vitreous humor of the eye and confirmed cases of Alzheimer's disease and Chronic Traumatic Encephalopathy.